Ocular Therapeutix Inc (OCUL)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
2,119,293,000
EV to revenue ratio (TTM)
32.21
EV to ebitda
-6.06
Financial Performance
Revenue (TTM)
52,055,000
Gross profit (TTM)
-178,162,000
EBITDA
-308,457,984
Profitability
Operating margin (TTM)
-609.00%
Profit margin
0.00%
Return on assets (TTM)
-34.90%
Return on equity (TTM)
-73.00%
Per Share Metrics
Revenue per share (TTM)
0.24
EPS
-1.4
Diluted EPS (TTM)
-1.4
Book value
2.37
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
0
Price to sales ratio (TTM)
40.71
Price to book ratio (TTM)
4.223
Growth
Quarterly earnings growth (YoY)
0.10%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
4
Buy
7
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.968